Sanofi | SNY - Ebitda



Sanofi reported EUR1.89B in EBITDA for its fiscal quarter ending in June of 2025.


Ebitda Change Date
AbbVie USD 4.4B 2.52B Mar/2025
Amgen USD 3.6B 147M Jun/2025
AstraZeneca USD 4.96B 127M Jun/2025
Bristol-Myers Squibb USD 3.27B 1.63B Jun/2025
Canopy Growth CAD -21827000 13.2M Jun/2025
Corcept Therapeutics USD 27.14M 23.27M Jun/2025
Drreddys Laboratories INR 24.64B 1.33B Jun/2025
Eli Lilly USD 7.5B 3.34B Jun/2025
Galapagos EUR -158708000 177.84M Mar/2025
Genmab DKK 376M 172M Jun/2025
GlaxoSmithKline GBP 3.18B 45M Jun/2025
Glaxosmithkline GBP 3.23B 1.54B Jun/2025
J&J USD 7.88B 1.76B Mar/2025
Merck USD 7.74B 625M Mar/2025
Novartis USD 6.17B 339M Jun/2025
Novartis USD 6.08B 739M Jun/2025
Pacira USD 54.32M 24.98M Jun/2025
Perrigo USD 129.1M 1.9M Jun/2025
Pfizer USD 5.32B 889M Jun/2025
Prestige Brands USD 79.65M 28.5M Jun/2025
Roche Holding CHF 12.68B 2.36B Jun/2024
Sanofi EUR 1.89B 971M Jun/2025
Sanofi EUR 1.89B 1.33B Jun/2025
Supernus Pharmaceuticals USD 41.47M 23.68M Jun/2025
UCB EUR 1.37B 715M Dec/2024
Zoetis USD 1.08B 110M Jun/2025